SK Capital Partners has completed the acquisition of a 39.75% stake, roughly 42.4 million shares, in titanium dioxide maker Venator from Huntsman for roughly $100 million. The deal includes a 30-month option for the purchase of Huntsman’s remaining approximate 9.5 million shares by SK at $2.15/share. Huntsman spun off Venator in a 2017 initial public offering.
“We are excited to engage with [SK founder] Barry Siadat and the SK Capital team, who have a strong reputation within the chemical industry for supporting long term growth and innovation,” said Simon Turner, president and CEO of Venator.
“Our business is poised for increased shareholder value creation as demand for our world class functional and specialty products continues to strengthen.” Venator said it remains “well positioned to deliver the full $55 million in EBITDA improvement from our 2020 business improvement program over the next two years. We look forward to implementing additional steps to strengthen our business and further unlock shareholder value.”
SK said in a regulatory filing 23 December that it intends to “engage in discussions with management or the board of directors of [Venator] about its business, operations, strategy, plans, and prospects, from time to time.” Discussions may concern “any extraordinary corporate transaction, a sale or transfer of a material amount of assets, a change in the board of directors or management, a material change in the capitalization, other material changes in the company’s business or corporate structure, or similar actions.”
Huntsman said that the sale will provide cash tax savings of approximately $150 million from the offset of a capital loss on the sale of Venator shares against the capital gain realized on the sale of its chemical intermediates and surfactants businesses in early January. The company said the Venator sale will secure a total related benefit of approximately $250 million in cash this year.
by Robert Westervelt
The total contract value is approximately €430 million. The project scope of work entails complete engineering services, equipment and material supply, installation and construction activities and, as an optional part of the scope, commissioning and start up.
Once it has implemented this project, Lenzing will have biological wastewater treatment plants that meet the best available techniques (BAT) quality standard at all its production sites.
The debate over the position of hydrogen in the new energy revolution has come to the fore again thanks to Japan’s hosting of the Olympic Games. But rather than showcasing how green this miracle new fuel is, it has highlighted its many problems.